Skip to main content
. 2023 Jan 13;14(1):26. doi: 10.1038/s41419-022-05534-w

Fig. 1. SF3B4 is upregulated and negatively correlates with survival in patients with ccRCC.

Fig. 1

A The expression of SF3B4 was downloaded and then analyzed from the TCGA database in normal (n = 72) and ccRCC (n = 533) tissues. B The mRNA levels of SF3B4 were detected by RT-qPCR in total 53 clinical samples. C Three groups of ccRCC and normal renal tissue were randomly selected and western blot was used to detect SF3B4 protein expression. D Hematoxylin and eosin (HE) staining of tumor and normal kidney tissues. Scale bar = 50 μm. E Immunohistochemical staining examined the SF3B4 expression in clinical samples. Scale bar = 50 μm. FI The mRNA levels of SF3B4 were compared with different clinicopathological parameters from TCGA‐KIRC: cancer versus normal tissues, G stage, T stage, N stage, and M stage. j RT-qPCR detected the SF3B4 expression in the ccRCC tissues of metastasis (n = 21) and non-metastasis (n = 21). K Poor prognosis and low overall survival were associated with high SF3B4 expression in TCGA‐KIRC. All data are expressed as the mean ± SEM of three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001 vs. their corresponding controls.